Diana Bernstein, Ph.D.
Director at Northpond Ventures
📍 Cambridge, Massachusetts, United States
Diana Bernstein is a Director at Northpond Ventures, focusing on investments in therapeutics. She holds a Ph. D. in Pharmacology from the University of Pennsylvania and a B. S. from the University of Maryland. Her previous experience includes roles at Vida Ventures and Merck, shaping her expertise in biopharma.
She believes in technologies that can redefine the treatment of neurodegenerative diseases by targeting the epigenetic basis of the illness.
Read the full overview →Experience
4 Years
Current Role
Director
Job Level
Mid-senior
Location
Cambridge, Massachusetts, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Diana cares about
Therapeutic Investing
As a Director at Northpond Ventures, she leads investments and serves on the boards of innovative therapeutics companies like Mestag and Code Biotherapeutics.
Neurodegenerative Diseases
Publicly supports new approaches to treating neurodegenerative diseases, specifically through technologies that target the epigenetic basis of the condition.
Career
Work history
12-2024
Director
Northpond Ventures
1-2023 - 12-2024
Principal
Northpond Ventures
6-2021 - 1-2023
Vice President
Northpond Ventures
12-2022
Board Director
Mestag Therapeutics
6-2022
Board Director
Code Biotherapeutics
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Education
BS
University of Maryland
PhD
University of Pennsylvania
Social presence
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.